We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




MRI Microscopy Provides Advance in Molecular Structures Imaging

By Biotechdaily staff writers
Posted on 08 May 2007
Researchers are utilizing magnetic resonance imaging (MRI) techniques to visualize nanoscale objects. More...
This technique brings MRI capability to the nanoscale level for the first time, and represents a major landmark in the quest to construct a microscope that could visualize individual atoms in three dimensions, according to researchers.

Utilizing MR force microscopy (MFRM), researchers from IBM at its Almaden Research Center (San Jose, CA, USA) have demonstrated two-dimensional (2D) imaging of objects as small as 90 nanometers, a major advancement on the path of 3D imaging at the atomic scale. Such imaging could ultimately provide a better understanding of how proteins function, which in turn, may lead to more efficient drug discovery and development.

MFRM provides imaging sensitivity that is 60,000 times better than traditional MRI technology. MFRM uses what is known as force detection to overcome the sensitivity limitations of conventional MRI to view structures that would otherwise be too small to be detected.

To achieve this, the research team developed specialized magnetic tips for their microscope, optimizing their ability to manipulate and detect the extremely weak magnetism of atomic nuclei. Conventional medical MRI characteristically operates on a scale at least 1,000 times coarser; even the most specialized MRI microscopy is limited to approximately 3 µm micrometers (3,000 nm).

This accomplishment could ultimately have major impact on the study of materials--ranging from proteins and pharmaceuticals to integrated circuits-- for which a detailed determination of the atomic structure is crucial. Knowing the precise location of specific atoms within tiny nanoelectronic structures, for example, would enhance designers' insight into manufacture and performance. The ability to directly image the exact atomic structure of proteins would help the development of new drugs.

The investigators published their findings in the April 2007 issue of the journal Nature Nanotechnology.


Related Links:
IBM

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Platelet Function Analyzer
PL-12
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.